NSC243928 mesylate

CAS No. 59988-01-1

NSC243928 mesylate( —— )

Catalog No. M36464 CAS No. 59988-01-1

NSC243928 mesylate binds to human lymphocyte antigen 6 (LY6), a cell growth inhibitor with anticancer activity, and induces cell death in triple-negative breast cancer cells in a LY6K-dependent manner.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 196 In Stock
5MG 312 In Stock
10MG 511 In Stock
25MG 787 In Stock
50MG 1058 In Stock
100MG 1395 In Stock
500MG 2673 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    NSC243928 mesylate
  • Note
    Research use only, not for human use.
  • Brief Description
    NSC243928 mesylate binds to human lymphocyte antigen 6 (LY6), a cell growth inhibitor with anticancer activity, and induces cell death in triple-negative breast cancer cells in a LY6K-dependent manner.
  • Description
    NSC243928 mesylate is a human lymphocyte antigen 6 (LY6) binder, which also acts as an inhibitor of cell growth and has anticancer activity.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    HuR
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    59988-01-1
  • Formula Weight
    503.59
  • Molecular Formula
    C23H25N3O6S2
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 10 mg/mL (19.86 mM; Ultrasonic (<60°C)
  • SMILES
    O=S(=O)(O)C.O=S(=O)(NC1=CC=C(NC=2C=3C=CC=CC3N=C4C=CC=CC42)C(OC)=C1)CC
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Senyi Benti, et al. ?Small Molecule Binds with Lymphocyte Antigen 6K to Induce Cancer Cell Death. Cancers (Basel). 2020 Feb 22;12(2):509.??
molnova catalog
related products
  • NRX-1933

    NRX-1933 is a molecular glue and enhances the interaction between an oncogenic transcription factor, β-Catenin, and its cognate E3 ligase, SCFβ-TrCP.

  • Talacotuzumab

    Talacotuzumab (JNJ 56022473) is an IgG1 fully humanized CD123 neutralizing monoclonal antibody containing a modified Fc structure.

  • Dibenzothiophene

    Dibenzothiophene (DBT) is a model compound for organic sulfur in fossil fuels.